biotech
biotech Articles
Merrimack Pharmaceuticals shares saw a handy gain early Tuesday after the company announced positive results for its late stage metastatic pancreatic cancer study.
Published:
Last Updated:
When Illumina issued an update on its sales for the third quarter, the numbers came in below what analysts were looking for, and as a result investors sent the stock lower.
Published:
Last Updated:
IntelliPharmaCeutics International Inc. (NASDAQ: IPCI) is watching its shares jump on Monday after the company announced that it received a tentative approval from the U.S. Food and Drug...
Published:
Last Updated:
Several analysts have weighed in with higher price targets on top of their ratings for Tesaro. Its shares hit a new 52-week high on Monday.
Published:
Last Updated:
On Monday morning, Merck, Mylan and Bristol-Myers Squibb made substantial runs, either up or down.
Published:
Last Updated:
Shares of Exelixis saw a handy gain early Monday morning after the company reported positive results from its mid-stage trial for the treatment of renal cell carcinoma.
Published:
Last Updated:
CRISPR Therapeutics expects to price more than 4 million shares in the range of $15 to $17 apiece for an initial public offering valued up to nearly $92 million.
Published:
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) has been on a meteoric rise over the past month. In this time the stock has gained over 150%, on what has been relatively little news for such a massive...
Published:
Last Updated:
In a new research report from Jefferies, many of the outstanding companies in pharmaceuticals and biotech space show up among the stocks to buy.
Published:
Last Updated:
24/7 Wall St. has collected several big FDA decisions and mid- to late-stage trials that should be coming up in November and December.
Published:
Last Updated:
Shares of Immunomedics dropped sharply on Wednesday after the company announced the pricing of its secondary offering.
Published:
Last Updated:
Trinity Biotech PLC (NASDAQ: TRIB) is watching its shares get halved on Tuesday after the company announced that it would withdraw one of its submissions to the U.S. Food and Drug Administration....
Published:
Last Updated:
Shares of Summit Therapeutics more than doubled on Tuesday after it was announced that it would be entering into a licensing deal with Sarepta Therapeutics.
Published:
Last Updated:
24/7 Wall St. has collected several big FDA decisions and mid-stage to late-stage trials that should be announced in October.
Published:
Last Updated:
Jaguar Animal Health Inc. (NASDAQ: JAGX) filed a Form S-1 with the U.S. Securities and Exchange Commission (SEC) regarding a secondary offering. The expected price of the 4.32 million shares is...
Published:
Last Updated: